Children's Hospital of Pittsburgh
Anesthesiology
Dr. Barbara Brandom, MD
|
|
Give Review
Barbara Brandom, MD is an expert in the field of Anesthesiology. He went to Perelman School of Medicine at the University of Pennsylvania. Barbara Brandom, MD is also a published physician. He has 91 publication published. The most recent publication is: Effects of cisatracurium in children during halothane-nitrous oxide anesthesia.
Publications
- Malignant Hyperthermia Deaths Related to Inadequate Temperature Monitoring, 2007-2012: A Report from The North American Malignant Hyperthermia Registry of the Malignan...
- From the Journal archives: Masseter muscle rigidity: a dose-related drug effect or an early manifestation of a rare potentially fatal pharmacogenetic disorder.
- Anesthetic drugs and onset of malignant hyperthermia.
- Unexpected MH deaths without exposure to inhalation anesthetics in pediatric patients.
- Neuromuscular diseases in children: a practical approach.
- Ryanodine receptor type 1 gene variants in the malignant hyperthermia-susceptible population of the United States.
- Case report: death in the emergency department: an unrecognized awake malignant hyperthermia-like reaction in a six-year-old.
- Special article: creation of a guide for the transfer of care of the malignant hyperthermia patient from ambulatory surgery centers to receiving hospital facilities.
- Identical de novo Mutation in the Type 1 Ryanodine Receptor Gene Associated with Fatal, Stress-induced Malignant Hyperthermia in Two Unrelated Families.
- Electronic communication and medical research: beyond the record.
- Special article: Future directions in malignant hyperthermia research and patient care.
- Complications associated with the administration of dantrolene 1987 to 2006: a report from the north american malignant hyperthermia registry of the malignant hyperthe...
- What happens when things go wrong?
- Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006.
- Ambulatory surgery and malignant hyperthermia.
- The association of malignant hyperthermia and unusual disease: when you're hot you're hot or maybe not.
- Administrative databases: are they useful for clinical analyses?
- Cardiac arrests and deaths associated with malignant hyperthermia in north america from 1987 to 2006: a report from the north american malignant hyperthermia registry ...
- Postoperative hyperthermia, rhabdomyolysis, critical temperature, and death in a former premature infant after his ninth general anesthetic.
- Delayed onset of malignant hyperthermia without creatine kinase elevation in a geriatric, ryanodine receptor type 1 gene compound heterozygous patient.
- Heatstroke in the super-sized athlete.
- XXIVth Annual Meeting of the European Malignant Hyperthermia Group.
- The genetics of malignant hyperthermia.
- The practicality and need for genetic testing for malignant hyperthermia.
- Desflurane, malignant hyperthermia, and release of compartment syndrome.
- Screening of the entire ryanodine receptor type 1 coding region for sequence variants associated with malignant hyperthermia susceptibility in the north american popul...
- Malignant hyperthermia in North America: genetic screening of the three hot spots in the type I ryanodine receptor gene.
- Patients with malignant hyperthermia demonstrate an altered calcium control mechanism in B lymphocytes.
- The effect on lung mechanics in anesthetized children with rapacuronium: a comparative study with mivacurium.
- Predicting recovery from deep neuromuscular block by rocuronium in children and adults.
- Neuromuscular blocking drugs in pediatric anesthesia.
- Unmasked residual neuromuscular block after administration of vecuronium for days.
- Neuromuscular blocking drugs in pediatric patients.
- Neuromuscular effects of rapacuronium in pediatric patients during nitrous oxide-halothane anesthesia: comparison with mivacurium.
- The incidence of tissue coring during the performance of caudal injection in children.
- Safety of outpatient dental anaesthesia for children.
- Effects of cisatracurium in children during halothane-nitrous oxide anesthesia.
- Age related variability in the effects of mivacurium in paediatric surgical patients.
- Cardiac output and onset time of different muscle relaxants.
- Postoperative management of laryngotracheal reconstruction.
- Pulmonary edema after airway obstruction.
- Intubation in children after 0.3 mg/kg of mivacurium.
- Administration of atropine and onset of neuromuscular block produced by atracurium in infants.
- Decreasing morbidity following laryngotracheal reconstruction in children.
- Recovery from doxacurium infusion administered to produce immobility for more than four days in pediatric patients in the intensive care unit.
- Combinations of high-dose vecuronium and mivacurium provide similar paralysis and intubation conditions to succinylcholine in paediatric patients.
- Effects of 0.86 mg/kg cisatracurium in an infant.
- Spontaneous versus edrophonium-induced recovery from paralysis with mivacurium.
- Accelerated onset and delayed recovery of neuromuscular block induced by mivacurium preceded by pancuronium in children.
- Neuromuscular blocking drugs in infants and children.
- Clinical pharmacology of mivacurium in pediatric patients less than off years old during nitrous oxide-halothane anesthesia.
- Dose-response calculations revisited.
- Synergism between atracurium and vecuronium in children.
- Synergism between atracurium and mivacurium compared with that between vecuronium and mivacurium.
- Dose response of succinylcholine at the adductor pollicis of children with cerebral palsy during propofol and nitrous oxide anesthesia.
- Frequency of train-of-four stimulation influences neuromuscular response.
- Enflurane, halothane, and isoflurane inhibit removal of 5-hydroxytryptamine from the pulmonary circulation.
- The inspired median effective dose, brain concentration at anesthesia, and cardiovascular index for halothane in young rats.
- Uptake and distribution of halothane in infants: in vivo measurements and computer simulations.
- Clinical pharmacology of atracurium in paediatric patients.
- Clinical pharmacology of atracurium in infants.
- Determination of atracurium in plasma by high-performance liquid chromatography.
- Pharmacokinetics of atracurium in anaesthetized infants and children.
- Understanding the response lag to tricyclics. I. Application of pulse-loading regimens with intravenous clomipramine.
- Atracurium infusion requirements in children during halothane, isoflurane, and narcotic anesthesia.
- Enflurane, halothane and isoflurane do not inhibit angiotensin converting enzyme activity.
- Mivacurium chloride (BW B1090U)-induced neuromuscular blockade during nitrous oxide-isoflurane and nitrous oxide-narcotic anesthesia in adult surgical patients.
- Clinical pharmacology of doxacurium chloride (BW A938U) in children.
- Pharmacokinetics of sufentanil in adolescent patients with chronic renal failure.
- Intravenous ranitidine antagonizes intense atracurium-induced neuromuscular blockade in rats.
- Comparison of mivacurium and suxamethonium administered by bolus and infusion.
- Dose-response relationship to mivacurium in humans.
- In vitro metabolism of mivacurium chloride (BW B1090U) and succinylcholine.
- Clinical pharmacology of mivacurium chloride (BW B1090U) in children during nitrous oxide-halothane and nitrous oxide-narcotic anesthesia.
- Effects of cholestatic hepatic disease and chronic renal failure on alfentanil pharmacokinetics in children.
- Rate of change of somatosensory evoked potentials during isoflurane anesthesia in newborn piglets.
- Atracurium and succinylcholine on the masseter muscle.
- Clinical pharmacology of pipecuronium in infants and children during halothane anesthesia.
- Mivacurium infusion requirements in pediatric surgical patients during nitrous oxide-halothane and during nitrous oxide-narcotic anesthesia.
- Neuromuscular and cardiovascular effects of high-dose vecuronium.
- Continuous epidural infusion of bupivacaine and fentanyl for erythromelalgia in an adolescent.
- Vecuronium infusion requirements in children during halothane-narcotic-nitrous oxide, isoflurane-narcotic-nitrous oxide, and narcotic-nitrous oxide anesthesia.
- Effects of bolus administration of ORG-9426 in children during nitrous oxide-halothane anesthesia.
- Masseter spasm and malignant hyperthermia: a retrospective review of a hospital-based pediatric otolaryngology practice.
- Mivacurium infusion during nitrous oxide-isoflurane anesthesia: a comparison with nitrous oxide-opioid anesthesia.
- Monitoring neuromuscular function in the pediatric patient.
- Frequency of anesthesia-related complications in children with Down syndrome under general anesthesia for noncardiac procedures.
- Genetics of malignant hyperthermia.
- The place of suxamethonium in pediatric anesthesia.
- Is there a link between malignant hyperthermia and exertional heat illness?
Schools
Perelman School of Medicine University of Pennsylvania
University Health Center
Chldns Hospital
Doctors Specialties
- Anesthesiology
- Pediatric Anesthesiology
Accepted Insurances
- CareSource
- HealthSmart
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- United Healthcare
- Wells Fargo Insurance
Education
-
University of Pittsburgh Medical Center -
Perelman School of Medicine at the University of Pennsylvania
Hospital
-
UPMC Presbyterian Shadyside
Helpful Reviews
Similar Doctors
|
|
Dr. Thomas E. Lace, MD |
|
|
Dr. Gretchen E. Medich, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard S. Plowey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Todd H. Biagini, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nicholas G. Bircher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael T. Maromonte, DO |
|
|
Dr. Adam P. Childers, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael H. Greene, MD |
|
|
Dr. Daniel J. Ford, MD |